Page last updated: 2024-08-24

triazoles and Genome Instability

triazoles has been researched along with Genome Instability in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beattie, D; Cadogan, EB; Cairns, J; Davies, BR; Dean, E; Farrington, PM; Fawell, SE; Finlay, MRV; Fok, JHL; Follia, V; Goldberg, FW; Hollingsworth, SJ; James, N; Karmokar, A; Lamont, GM; Ling, S; Nikkilä, J; O'Connor, LO; O'Connor, MJ; Ramos-Montoya, A; Smith, A; Vazquez-Chantada, M; Wijnhoven, PWG; Willis, SE; Wilson, J	1
Kontoyiannis, DP; Lewis, RE; Lortholary, O; Roilides, E; Spellberg, B; Walsh, TJ	1

Other Studies

2 other study(ies) available for triazoles and Genome Instability

Article	Year
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity. Nature communications, 2019, 11-07, Volume: 10, Issue:1 Topics: A549 Cells; Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; DNA-Activated Protein Kinase; Doxorubicin; Drug Synergism; Genomic Instability; Humans; Lung Neoplasms; Mice; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Glycols; Protein Kinase Inhibitors; Purines; Pyrans; Radiation Tolerance; Radiotherapy; Triazoles; Xenograft Model Antitumor Assays	2019
How does antifungal pharmacology differ for mucormycosis versus aspergillosis? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole	2012

Article

Year

AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity.

Nature communications, 2019, 11-07, Volume: 10, Issue:1

Topics: A549 Cells; Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; DNA-Activated Protein Kinase; Doxorubicin; Drug Synergism; Genomic Instability; Humans; Lung Neoplasms; Mice; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Glycols; Protein Kinase Inhibitors; Purines; Pyrans; Radiation Tolerance; Radiotherapy; Triazoles; Xenograft Model Antitumor Assays

2019

How does antifungal pharmacology differ for mucormycosis versus aspergillosis?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54 Suppl 1

Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cell Membrane; Cell Wall; Drug Resistance, Multiple, Fungal; Ergosterol; Gene Duplication; Genome, Fungal; Genomic Instability; Humans; Itraconazole; Microbial Sensitivity Tests; Mucormycosis; Pyrimidines; Rhizopus; Species Specificity; Triazoles; Virulence Factors; Voriconazole

2012